Shinpoong Pharmaceutical expands clinical trial institutions…’accelerates’ the development of COVID-19 treatment
Market capitalization index by size is about to change regularly… Candidate groups such as Shinpoong Pharmaceutical and Jinwon Life Science
Shinpoong Pharmaceutical’s’Piramax’ approved for Phase 2/3 clinical trial in the Philippines for COVID-19 treatment
Second Moder or Corona 19 vaccine after Pfizer is also approved… What about Moder or related stocks Celltrion, kpx Life Science, Shinpoong Pharmaceutical, Woori Bio, and Yuhan Corporation?
![[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax… Checking the Phase 3 report”](http://www.thevaluenews.co.kr/data/cheditor4/2101/a38c3e468da1168cddb4551380c71ccc02bba011.JPG "[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax… Checking the Phase 3 report”")
